Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Standard of care
A guideline for the treatment of a condition that can be general or specific. Scientific evidence is gathered to help professionals determine the level of care a patient should expect
See also:
Primary Care Trust (PCT)
Quality of life (QOL)
Related terms
Health Maintenance Organisation (HMO), Incremental cost-effectiveness ratio (ICER), Concordance programme, NHS Evidence, Cost-effectiveness analysis (health economics), Off-label use, Primary care, Primary Care Trust (PCT), Defined daily dose (DDD), Strategic health authority (SHA), Commissioning (health), Acute care, Foundation Trust (FT), Cost-effective (healthcare economics), Concordance,
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
- Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
- ASH 2022: bad blood but big advances
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Alzheimer’s Society urges UK government to deliver on dementia plan
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Sanofi backs vaccines unit with €350m Canadian facility
- World Health Organization releases latest set of COVID-19 guidelines
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
